Hydroxylated polychlorinated biphenyl (OH-PCB) is a major metabolite of PCB, which is an endocrine disruptor. In this study, we investigated the neurobehavioral effects of prenatal exposure to a very low dose of OH-PCB (4-hydroxy-2′, 3, 3′, 4′, 5′-pentachlorobiphenyl, 4-OH-pentaCB) in mice. 4-OHpentaCB, dissolved in corn oil, was orally given at 0.1 g/30 l/animal/day to pregnant mice from gestation days 11 to 17. In the open field test, the number of ambulation and rearing drastically increased among 4-OH-pentaCB exposed mice compared with the control. However, 4-OH-pentaCB exposure had no effect on passive avoidance. These results suggest that an extremely low dose of 4-OH-pentaCB may selectively disrupt neurobehavioral functions involved in ambulation and rearing in mice.
INTRODUCTION
Hydroxylated PCB is a major metabolite of polychlorinated biphenyl (PCB). The level of hydroxylated PCBs (OH-PCBs) in blood has been shown to be 10-20% of the total PCB levels in Canadian Inuit, Latvian and Swedish men. 1, 2) Maternal exposure of rats to 5 or 25 mg/kg body weight of PCB mixture (Aroclor 1254) from gestation days 10 to 16 resulted in selective accumulation of OH-PCBs in fetal plasma and the brain. 3) Perinatal exposure to PCBs, endocrine disruptors, has been reported to produce neurologic impairment in many species, including humans. PCBs cause hyperactivity, stereotypic circling, and decreased motor coordination in mice. [4] [5] [6] [7] Recent studies have shown that endocrine disruptors, such as bisphenol A, have been reported to produce an inverted-U dose-response curve for stimulation of the proliferation of human prostate cancer cells, with maximum stimulation occurring at very low concentrations, 8, 9) and no stimulation occurring at high concentrations.
In this study we investigated the neurobehavioral effects of prenatal exposure to a low dose of one of OH-PCBs, 4-hydroxy-2′, 3, 3′, 4′, 5′-pentachlorobiphenyl (4-OH-pentaCB), in mice.
MATERIALS AND METHODS
Animals and Treatments ---Six mated ddY mice (SLC, Shizuoka, Japan) arrived on gestation day (GD) 5 in our laboratory, and were housed individually in cages (340 × 225 × 130 mm) with a bedding of paper chips, in the animal center of the Graduate School of Pharmaceutical Sciences. Throughout the experiment, a 12 : 12-hr light : dark cycle was kept with lights on from 08:00-20:00. The temperature was maintained at 22 ± 2°C. Standard mouse chow and tap water were freely available to the animals. 4-OH-pentaCB, obtained from AccuStandard Chemicals, (New Haven, CT, U.S.A.; purity of 97.7%) was dissolved in corn oil and administered orally at 0.1 µg/30 µl/animal once a day from GD11 to GD17. The control group was given pure corn oil at 30 µl/animal. After weaning on postnatal day (PND) 21, offspring was separated by sex and housed in standard cages until the onset of behavioral testing. Dams were weighed on GD5, 9, 11, 13 and 16. The offspring was weighed on PND 28, 36 and 45. Open Field Test ---Open field testing was done on 4-week-old offspring and dams. The open field used for measuring ambulation, rearing, defecation, urination, face washing and grooming was a white circle arena with a diameter of 600 mm. The floor was equally divided into 19 segments. It was illuminated by an incandescent lamp (100 W) hanging 800 mm above the floor. The total session duration *To whom correspondence should be addressed: Department of Environmental and Molecular Health Sciences, Graduate School of Pharmaceutical Sciences Kumamoto University, 5-1 OeHonmachi, Kumamoto 862-0973, Japan. Tel. & Fax: +81-96-371-4334; E-mail: takahama@gpo.kumamoto-u.ac.jp was 5 min, subdivided into five 1-min intervals for analysis. The occurrences of rearing, defecation, urination, face washing, and grooming in each session were counted. Ambulation was determined according to the number of segments crossed on the floor. Thirty minutes after the first session, the second session was performed. This test was carried out during the light phase of the cycle. Passive Avoidance Test ---Passive avoidance testing was done on 6-7-week-old offspring and dams. The apparatus consisted of two compartments: one was a light chamber (320 × 320 × 270 mm high), and another one a dark chamber (155 × 96 × 180 mm high) with a grid floor. As a training session, the mice were gently placed in the light chamber and allowed to escape into the dark chamber through the slit door, and the latency time to enter the dark chamber was measured. Then, they received a 150-volt foot shock for 5 sec and were withdrawn from the chamber. At 24 hr after the training session, as a testing session, the animals were again placed in the same chamber and the latency time required for entry into the dark chamber was measured. As a cutoff time for latency in a testing session, 600 sec was used. This test was carried out during the light phase of the cycle. Data Analysis ---Data were analyzed using unpaired t-tests to assess the statistical significance between control and 4-OH-pentaCB data. p < 0.05 was considered statistically significant.
RESULTS

Reproductive and Developmental Outcomes
The dose of 4-OH-pentaCB used in this study did not affect the gestational weight gain of the dams. Other reproductive and developmental parameters including gestation length, litter size, percentage of live births, birth weight and postnatal growth were also unaffected. There were no effects of 4-OHpentaCB exposure on the weight gain and footstep of offspring. Further, 4-OH-pentaCB-exposed dams and their offspring performed normally in traction tests and showed a normal pain response to a tail pinch.
Open Field Activity
In 4-OH-pentaCB-exposed male and female offspring, the number of ambulation and rearing increased remarkably in the first and the second trials (Fig. 1) . However, other parameters such as defecation, urination, face washing, and grooming were not affected, expect for an increase in defecation and a decrease in face washing in female offspring in the first trial. Dams exposed to 4-OH-pentaCB were also subjected to neurobehavioral examination. No neurobehavioral parameters were affected by the exposure.
Passive Avoidance Learning
4-OH-pentaCB exposure had no effect on passive avoidance response either in male or female of offspring.
DISCUSSION
This is the first documentation showing that prenatal exposure to a very low dose of 4-OH-pentaCB causes remarkable neurobehavioral effects in mice, shown as increases in the number of ambulation and rearing in the open field. The effects were relatively selective, because they were not accompanied by changes in footstep, grip strength and pain response. Further, reproductive and developmental data of the dams and their offspring showed no effects from 4-OH-pentaCB exposure, indicating that 4-OH- Although it is well known that both PCBs and their hydroxylated metabolites disrupt thyroid hormone homeostasis by interacting with TTR, it has also been reported that prenatal and perinatal exposure to PCBs produce neurobehavioral effects similar to those observed in the present study. In these reports, however, the selectivity of the effects seems to be lower compared with that of the present study. In about one-half of CD-1 mice exposed to 3,4,3′,4′-tetrachlorobiphenyl (4-CB) at a dose of 32 mg/kg from GD10 to 16, a neurological syndrome consisting of increased locomotor activity occurred. 6 ) But body weight gain in the offspring with the neurological syndrome was significantly depressed. Further, the offspring of mice exposed to the same dose of 4-CB during gestation also revealed a neurological syndrome consisting of intermittent stereotypic circling and hyperactivity. In addition, the offspring showed other symptoms such as impaired forelimb grip strength, inability to traverse a wire rod, and so forth. Similar effects have been reported in offspring treated with Aroclor 1254, a mixture of PCBs. 3) In the present study, 4-OH-pentaCB exposure did not impair passive avoidance responses in male and female offspring, although a disruption in another avoidance response has been observed in mice exposed in utero to high doses of PCBs. 5, 6) This difference seems to come from differences in exposure doses and experimental periods. Previously, we reported that prenatal exposure to diethylstilbestrol (DES) impaired the passive avoidance responses of mice.
10) However, we found that motor and emotional functions were not so disrupted by DES exposure (unpublished data). The present results indicate that the brain disrupting action of OH-PCB, unlike that of DES, occurs on motor and/or emotional functions rather than on learning or memory functions.
The mechanisms underlying the increase in the occurrences of ambulation and rearing are still unknown. The following discussion, however, may have some merit. Among various substances known to change ambulation in mice, methamphetamine is one of the most potent. Direct administration of methamphetamine into the nucleus accumbens possessing dopaminergic neurons causes a prominent increase in the number of ambulation.
11) Further, it has been known that methamphetamine decreased levels of dopamine transporter (DAT) and vesicular monoamine transporter 2 (VMAT2) in the striatum. 12, 13) Therefore, it seems possible that methamphetamine-induced increase in ambulation might be caused by a decrease in DAT and VMAT2. PCBs also decrease levels of DAT and VMAT2, causing a reduction in striatal dopamine. 14) Further studies are needed on whether 4-OH-pentaCB affects the dopamine system, including DAT and VMAT2 to cause an increase in ambulation.
A recent in vitro study revealed that 4-OHpentaCB at 10 -10 M suppressed thyroid hormone receptor (TR)-mediated transcriptional activation by T 3 (10 -7 M) on DR-4 (TRE)-Luc in CV-1 cells. 15) Furthermore, Umezu et al. reported that the perinatal administration of propylthiouracil, a thyroid hormone synthesis inhibitor, to pregnant ICR mice caused an increase in ambulation in matured male offspring. 16) This being the case, it seems reasonable that 4-OH-pentaCB may suppress TR-mediated transcription and consequently increase the number of ambulation in mice. Apart from the above, Kester et al. demonstrated that various OH-PCBs, including 4-OH-pentaCB, were extremely potent inhibitors of human estrogen sulfotransferases. 17) In addition, some OH-PCBs competitively bind to estrogen receptors and exhibit estrogenic activity in the mouse uterus. 18) Further studies are undoubtedly needed to elucidate mechanisms of brain disrupting actions caused by prenatal exposure to a minute amount of 4-OH-pentaCB. Nevertheless, the present findings reveal that prenatal exposure to an extremely low dose of 4-OH-pentaCB may selectively disrupt neurobehavioral functions involved in ambulation and rearing in mice, raising the possibility that changes in ambulation and rearing in the open field may be a very sensitive marker for assessing the brain disrupting actions of environmental chemicals such as PCBs and their derivatives.
